The JKTG Foundation recently awarded funding to Laura Heiser, Ph.D., Associate Professor and Vice Chair of Biomedical Engineering at the Oregon Health & Science University (OHSU) School of Medicine, to develop a prototype multiscale model designed to predict therapeutic responses of tumor ecosystems – a new frontier in breast cancer research.
This work aims to identify effective therapies for women diagnosed with triple-negative breast cancer, an aggressive disease that frequently affects young women and is twice as common in Black and Hispanic women.
Today, roughly 40 percent of patients do not experience long-term benefits from standard therapy and there is urgent need for effective treatment regimens.
The project involves team members from OHSU, Indiana University and Brigham and Women’s Hospital. Learn more about this work.
JKTG Funding@Work: We aim to change health care for the better by funding unbiased research through a unique selection of researchers, scientists and projects. Recent publications featuring JKTG-supported work includes:
Outlook and opportunities for engineered environments of breast cancer dormancy by Nathan R. Richbourg, Ninette Irakoze, Hyuna Kim, and Shelly R. Peyton. appears in Vol. 10, Issue 10, Science Advances
Order now! Life comes at you fast when you’re traveling 180 miles per hour. For Ted Giovanis, it’s also where you can learn the most valuable lessons.
Order your copy of this must-read life manual today.
Ted’s Take Highlights: For more lessons on life and leadership, follow Ted Giovanis on LinkedIn, Instagram and Twitter.
*The Last Tenth is a racing term that describes fighting for time; getting a better last second in a timed lap. But the mental toughness required to achieve the last tenth applies to everyone, anywhere, not just race car drivers on a track. No matter where your starting line may be, that start ignites the toughness that leads to success.
*The term stakeholder is used often in healthcare and can conjure up differences and finger pointing instead of commonalities. To successfully achieve shared objectives, particularly one as important as caring for patients, we need to consider a quote by Ken Burns: “The thing that I’ve learned is that there is no ‘them.’ This is what everybody does: make a distinction about ‘them.’ It’s just ‘us’.”
Team TGM, the championship-winning race team of Ted Giovanis that competes in the IMSA Michelin Pilot Challenge supports the JKTG Foundation. Team TGM’s #46 car took a fourth-place finish at Sebring and next hits Laguna May 10-12. Follow the action @TeamTGM and @TedGiovanis for Ted’s behind-the-scenes insights.
Featured news
Ted’s Take: It’s about the money
Money is what seems to drive things and money is what seems to drive organizations too. They all start with an overriding moral goal but after a while things often turn toward more money.
Ted’s Take: The best patient advocate? You.
When you’re a patient, you are kind of vulnerable. You have a problem, are often sketchy about what it is and the potential treatment or therapy needed. The bigger the problem, the more vulnerable you are. This makes you a perfect advocate.
JKTG Foundation targets effective treatments for triple-negative breast cancer
The Jayne Koskinas Ted Giovanis Foundation for Health and Policy (JKTG Foundation) today announced funding to develop a prototype multiscale model designed to predict therapeutic responses of tumor ecosystems – a new frontier in breast cancer research.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133